Chemical Compound

Lopinavir free amine

CAS Registry Number 192726-05-9
Lopinavir free amine chemical structure
Primary Record

Lopinavir free amine

In stock
9,947 g
Purity
99.1 %
CAS
192726-05-9

Compound Identifiers & Properties

CAS
192726-05-9
PubChem CID
17755107
SMILES
CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C[C@@H]([C@H](CC2=CC=CC=C2)N)O)N3CCCNC3=O
Canonical SMILES
CC(C)[C@@H](C(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@@H](N)Cc1ccccc1)N1CCCNC1=O

Names & Synonyms

  • Lopinavir free amine
  • Lopinavir EP Impurity A
  • 192726-05-9
  • UNII-395TR49R7C
  • RefChem:201500
  • LOPINAVIR IMPURITY A
  • 395TR49R7C
  • LOPINAVIR AMINO ALCOHOL
  • Lopinavir specified impurity A
  • trans-Phytoene (Technical grade)
  • DTXSID70172869
  • Lopinavir specified impurity A [EP]
  • DTXCID2095360
  • CTK8E2870
  • LOPINAVIR IMPURITY A [WHO-IP]
  • (S)-N-[(2S,4S,5S)-5-AMINO-4-HYDROXY-1,6-DIPHENYLHEXAN-2-YL]-3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANAMIDE
  • LOPINAVIR AMINO ALCOHOL [WHO-IP]
  • ZINC22048446
  • AKOS027447531
  • LOPINAVIR IMPURITY A [EP IMPURITY]
  • LOPINAVIR FREE AMINE [USP IMPURITY]
  • AJ-80758
  • LOPINAVIR IMPURITY A (EP IMPURITY)
  • DB-290297
  • LOPINAVIR FREE AMINE (USP IMPURITY)
  • Lopinavir impurity, lopinavir free amine- [USP]
  • RT-014026
  • (S)-N-((2S,4S,5S)-5-Amino-4-hydroxy-1,6-diphenylhexan-2-yl)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide
  • Lopinavir impurity, lopinavir free amine-(USP)
  • Lopinavir impurity, lopinavir free amine-[USP]
  • (2S)-N-[(2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide
  • N-((2S,4S,5S)-5-Amino-4-hydroxy-1,6-diphenylhexan-2-yl)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide, (S)-
  • Q27256862
  • (2S)-N-((1S,3S,4S)-1-BENZYL-4-AMINO-3-HYDROXY-5-PHENYLPENTYL)-3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANAMIDE
  • 1(2H)-Pyrimidineacetamide, N-((1S,3S,4S)-4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)-
  • 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)-
  • 540-04-5
  • (|AS)-N-[(1S,3S,4S)-4-Amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-|A-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
  • (alphaS)-N-[(1S,3S,4S)-4-Amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
  • (S)-N-[(2S,4S,5S)-5-Amino-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2
  • 1(2H)-PYRIMIDINEACETAMIDE, N-((1S,3S,4S)-4-AMINO-3-HYDROXY-5-PHENYL-1-(PHENYLMETHYL)PENTYL)TETRAHYDRO-.ALPHA.-(1-METHYLETHYL)-2-OXO-, (.ALPHA.S)-
  • 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2-oxo-, (aS)-; 1(2H)-Pyrimidineacetamide, N-[4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2-oxo-, [1S-[1R*(R*),3R*,4R*]]-; Lopinavir Imp. A (EP)
  • 7,7',8,8',11,11',12,12'-Octahydro-?,?-carotene; 2,6,10,14,19,23,27,31-octamethyl-2,6,10,14,16,18,22,26,30-dotriacontanonaene; all-trans-7,7',8,8',11,11',12,12'-Octahydro-lycopene; (all-E)-Phytoene; all-trans-Phytoene